# US 2017/0281598 A1 · Methods and compositions for treating clostridium difficile associated disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0281598 A1
- Document ID: US20170281598A1
- Status: Published application
- Kind: A1
- Application number: 15/630,345
- Filed: 2017-06-22
- Published: 2017-10-05
- Earliest claimed: 2014-06-16
- Assignees: The Lauridsen Group Incorporated
- Applicants: The Lauridsen Group, Inc.
- Inventors: Eric WEAVER; Abigail HENDERSON; Christopher DETZEL
- Web page: https://patentgrep.com/patent/US20170281598A1

## CPC

- A61K 31/4164: 1,3-Diazoles
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A61K 38/14: Peptides containing saccharide radicals; Derivatives thereof {, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin}
- A61K 39/395: Antibodies (agglutinins A61K38/36 {; as drug carriers A61K47/50}); Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- C07K 16/00: Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 2039/505: {comprising antibodies}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION

## Abstract

The present invention provides methods for treating and preventing the reoccurrence of C. diff infection by administering an immunoglobulin concentrate in conjunction with a low protein diet.

## Claims

### Claim 1

A method of treating a Clostridium difficile (C. diff.) infection in a subject, the method comprising: administering to the subject a) an effective amount of one or more antibiotics effective against C. diff, b) an immunoglobulin concentrate (IgC), and c) a low protein diet for a time period sufficient to reduce, attenuate, or inhibit the effects of of the C. diff infection; wherein the IgC comprises gamma-globulin isolated from an animal source selected from serum, plasma, egg, or milk; wherein the IgC comprises at least 40% IgC by weight; and wherein the low protein diet provides ≦75% of the subject's daily protein requirement.

### Claim 2 (depends on 1)

The method of claim 1 whereby the administration continues for a time period of at least two weeks.

### Claim 3 (depends on 1)

The method of claim 1 whereby the IgC is administered in an amount sufficient to provide a total of about 0.10-3.0 g protein/kg/day.

### Claim 4 (depends on 1)

The method of claim 1 whereby the IgC is administered in an amount sufficient to provide a total of about 0.001-0.24 g of protein/kg/day.

### Claim 5

(canceled)

### Claim 6 (depends on 1)

The method of claim 1 whereby the low protein diet provides ≦50% of the person's daily protein requirement.

### Claim 7 (depends on 1)

The method of claim 1 whereby the low protein diet provides ≦25% of the person's daily protein requirement.

### Claim 8

(canceled)

### Claim 9 (depends on 1)

The method of claim 1 whereby the IgC comprises at least 60% by weight immunoglobulins.

### Claim 10

(canceled)

### Claim 11 (depends on 1)

The method of claim 1 whereby the immunoglobulin concentrate is serum bovine immunoglobulin.

### Claim 12

(canceled)

### Claim 13 (depends on 1)

The method of claim 1 wherein the one or more antibiotics being administered are selected from the group consisting of vancomycin and metronidazole.

### Claim 14

(canceled)

### Claim 15 (depends on 1)

The method of claim 1 whereby the IgC is administered orally.

### Claim 16 (depends on 1)

The method of claim 1 whereby the IgC provides at least 20% of the person's total protein.

### Claim 17

(canceled)

### Claim 18 (depends on 1)

The method of claim 1 whereby the administration continues for a time period of at least 7 days.

### Claim 19 (depends on 1)

The method of claim 1 whereby the administration continues for a time period of at least 10 days.

### Claim 20

(canceled)
